Dr. Guy Van Hazel on Selective Internal Radiation Therapy and its Effects on Extrahepatic Colorectal Cancer

October 15, 2015

Dr. Guy Van Hazel speaks about finding a potential survival advantage for extrahepatic colorectal cancer metastases patients that undergo selective internal radiation therapy.

Guy Van Hazel, MD, Medical Oncologist, Mount Hospital and School of Medicine University of Western Australia, speaks about finding a potential survival advantage for extrahepatic colorectal cancer (CRC) metastases patients that undergo selective internal radiation therapy (SIRT).

Survival data is not yet available. However, for patients that underwent SIRT, time to progression of liver metastases was 7.9 or 8 months; which Van Hazel says is significant and could be indicative of a possible survival benefit in further studies.